People who have had surgery to remove pancreatic cancer may benefit from better survival time, without the disease progressing, if they are treated with the drug gemcitabine for 6 months after surgery, a study has shown. The randomized trial investigated treatment with gemcitabine (a chemotherapy drug marketed in the US under the brand name Gemzar) given in addition to surgery, comparing this with observation alone, and the results are published in the journal JAMA...
-
Source: http://www.medicalnewstoday.com/articles/267085.php
--
Manage subscription | Powered by rssforward.com
09 Oct, 2013
-
Source: http://www.medicalnewstoday.com/articles/267085.php
--
Manage subscription | Powered by rssforward.com
Post a Comment